{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:09:06Z","timestamp":1789654146929,"version":"4.0.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019817","name":"Peter French Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019817","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jacep.2022.09.020","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T04:59:50Z","timestamp":1667192390000},"page":"394-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Subcutaneous and Transvenous Defibrillators in Arrhythmogenic Right\u00a0Ventricular Cardiomyopathy"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9435-0145","authenticated-orcid":false,"given":"Weijia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3432-070X","authenticated-orcid":false,"given":"Alessio","family":"Gasperetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel F.","family":"Sears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Tichnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittney","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harikrishna","family":"Tandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Calkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2022.09.020_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/europace\/euy063","article-title":"Diagnostic and therapeutic strategies for arrhythmogenic right ventricular dysplasia\/cardiomyopathy patient","volume":"21","author":"Wang","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2022.09.020_bib2","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2022.09.020_bib3","article-title":"Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: predictors of appropriate therapy, outcomes, and complications","volume":"6","author":"Orgeron","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacep.2022.09.020_bib4","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2022.09.020_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2014-000198","article-title":"A\u00a0systematic review of ICD complications in randomised controlled trials versus registries: is our \u2018real-world\u2019 data an underestimation?","volume":"2","author":"Ezzat","year":"2015","journal-title":"Open Heart"},{"key":"10.1016\/j.jacep.2022.09.020_bib6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/CIRCEP.113.000392","article-title":"Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications","volume":"6","author":"Schinkel","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2022.09.020_bib7","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1161\/01.CIR.0000103130.33451.D2","article-title":"Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"108","author":"Corrado","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2022.09.020_bib8","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jacc.2017.06.040","article-title":"Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study","volume":"70","author":"Boersma","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2022.09.020_bib9","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa1915932","article-title":"Subcutaneous or transvenous defibrillator therapy","volume":"383","author":"Knops","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2022.09.020_bib10","article-title":"Subcutaneous implantable cardioverter-defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia: a transatlantic experience","volume":"7","author":"Orgeron","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacep.2022.09.020_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijcard.2019.01.041","article-title":"Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: Results from an Italian multicenter registry","volume":"280","author":"Migliore","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacep.2022.09.020_bib12","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the task force criteria","volume":"121","author":"Marcus","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2022.09.020_bib13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/07853890109002089","article-title":"The RAND-36 measure of health-related quality of life","volume":"33","author":"Hays","year":"2001","journal-title":"Ann Med"},{"key":"10.1016\/j.jacep.2022.09.020_bib14","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0002-9149(89)90496-7","article-title":"A\u00a0brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index)","volume":"64","author":"Hlatky","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2022.09.020_bib15","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1540-8159.2006.00408.x","article-title":"Measurement of patient fears about implantable cardioverter defibrillator shock: an initial evaluation of the Florida Shock Anxiety Scale","volume":"29","author":"Kuhl","year":"2006","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacep.2022.09.020_bib16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.1540-8167.2005.40134.x","article-title":"Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey","volume":"16","author":"Burns","year":"2005","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2022.09.020_bib17","first-page":"585","article-title":"Measuring stigma across neurological conditions: the development of the Stigma Scale for Chronic Illness (SSCI)","volume":"18","author":"Rao","year":"2009","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"key":"10.1016\/j.jacep.2022.09.020_bib18","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehz103","article-title":"A\u00a0new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy","volume":"40","author":"Cadrin-Tourigny","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2022.09.020_bib19","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.hrthm.2018.05.011","article-title":"Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator","volume":"15","author":"Theuns","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2022.09.020_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/CIRCULATIONAHA.121.057816","article-title":"Efficacy and Safety of appropriate shocks and antitachycardia pacing in transvenous and subcutaneous implantable defibrillators: analysis of all appropriate therapy in the PRAETORIAN trial","volume":"145","author":"Knops","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2022.09.020_bib21","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1161\/01.CIR.0000145610.64014.E4","article-title":"Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators","volume":"110","author":"Wathen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2022.09.020_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jacc.2014.04.035","article-title":"Ventricular arrhythmias in the North American multidisciplinary study of ARVC","volume":"64","author":"Link","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2022.09.020_bib23","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/j.ijcard.2012.09.015","article-title":"Impact of accelerated ventricular tachyarrhythmias on mortality in patients with implantable cardioverter-defibrillator therapy","volume":"167","author":"Schukro","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacep.2022.09.020_bib24","first-page":"223","article-title":"Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: single-center experience","volume":"32","author":"Ferrari","year":"2016","journal-title":"J\u00a0Arrhythmia"},{"key":"10.1016\/j.jacep.2022.09.020_bib25","first-page":"806","article-title":"Accelerated battery depletion in subcutaneous implantable cardioverter-defibrillators","volume":"7","author":"Narayanan","year":"2021","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacep.2022.09.020_bib27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.hrthm.2018.09.029","article-title":"A\u00a0novel tool to evaluate the implant position and predict defibrillation success of the\u00a0subcutaneous implantable cardioverter-defibrillator: The PRAETORIAN score","volume":"16","author":"Quast","year":"2019","journal-title":"Heart Rhythm"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X22008465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X22008465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:31:12Z","timestamp":1762500672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X22008465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2405500X22008465"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2022.09.020","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subcutaneous and Transvenous Defibrillators in Arrhythmogenic Right\u00a0Ventricular Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2022.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier on behalf of the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}